Clinical impact of chromosome 1 aberrations in neuroblastoma: a metaphase and interphase cytogenetic study.
Neuroblastoma tumors are characterized by aberrations of chromosome 1. Rapid detection of these chromosomal aberrations at diagnosis could give important clues to outcome and therapy. We attempted to detect numerical and structural aberrations of chromosome 1 not only by classical metaphase cytogenetics but also by interphase cytogenetics in order to overcome difficulties of karyotyping due to diminished metaphase quality and quantity in primary neuroblastoma samples. Karyotypic changes of chromosome 1 in 53 primary neuroblastomas were evaluated. In addition, we successfully performed interphase cytogenetics using single and double in situ hybridization procedures with chromosome 1-specific repetitive DNA probes on nuclei preparations obtained from 46 and 20 tumors, respectively. Polysomies of structurally normal chromosomes 1 were predominantly seen in tumors with good prognosis, whereas deletions of 1p material were nearly exclusively confined to progressive tumors. Numerical and structural chromosome 1 aberrations as studied by metaphase and interphase cytogenetics are thus valuable prognostic markers in neuroblastoma.
Christiansen
H
H
Kinderklinik, Justus-Liebig Universität, Giessen, Germany.
Schestag
J
J
Christiansen
N M
NM
Grzeschik
K H
KH
Lampert
F
F
D002872:Chromosome Deletion; D002878:Chromosomes, Human, Pair 1; D015342:DNA Probes / Q000235:genetics; D006801:Humans; D007399:Interphase; D007621:Karyotyping; D008677:Metaphase; D009447:Neuroblastoma / Q000235:genetics*; D009693:Nucleic Acid Hybridization; D011379:Prognosis; D012091:Repetitive Sequences, Nucleic Acid / Q000235:genetics; D014314:Trisomy
D015342:DNA Probes